Friuli Venezia Giulia now has its first specialists in Pharmacology and Clinical Toxicology. Today (Friday 21st November), the final exams of the first course of the School of Specialisation in Pharmacology and Clinical Toxicology at the University of Trieste, promoted in collaboration with the Research Hospital Burlo Garofolo, in partnership with the Pharmacology departments of the Research Hospital and Oncological Reference Centre (CRO) of Aviano, and the local health authorities AsuFc and AsuGi.

This is one of the most prestigious training courses in contemporary pharmacology, at the crossroads between clinical research, drug governance, therapy safety and therapeutic innovation. The specialisation in Pharmacology and Clinical Toxicology qualifies graduates to carry out professional activities in areas crucial to modern healthcare: therapeutic drug monitoring, pharmacogenetics, pharmacovigilance, pharmacoeconomics, clinical trials, appropriate prescriptions, therapeutic innovation management and related clinical and care activities.

The course is open to graduates in Medicine, but also in Pharmacy, Pharmaceutical Chemistry and Technology, Biology and other scientific degrees; it is also equivalent to the specialisation in Hospital Pharmacy.

At the end of the exams, the Examination Board – composed of Professors Marianna Lucafò and Raffaella Franca of the University of Trieste, Dr Erika Cecchin of the Oncological Reference Centre in Aviano, Professor Massimo Baraldo of the University of Udine and AsuFc, and chaired by Professor Gabriele Stocco of the University of Trieste and Burlo, who is also the director of the specialisation school – announced the first four specialists trained in our region.

The creation of this specialisation school, strongly supported by Professor Giuliana Decorti and Dr Anna Arbo, who heads the Pharmacy Department at Burlo, represents a significant step forward at a time when the role of the clinical pharmacologist is increasingly central to drug policy and the sustainability of regional and national health systems.

'This is an important milestone for the Department of Medicine, Surgery and Health Sciences (DSM) at the University of Trieste, the result of the University's policy of investing in the growth of the number of specialisation schools, in order to provide the regional healthcare system with key professionals trained in our region,' said Luigi Murena, head of the DSM Department